India’s Hetero says COVID-19 drug reduces hospitalisations in late-stage trial July 9, 2021 Auto Bot News 0 Molnupiravir is an antiviral therapy Merck & Co is developing with Ridgeback Biotherapeutics for the treatment of non-hospitalised COVID-19 patients.
